Inspiration Biopharmaceuticals, a US-based company developing a treatment for blood disorders backed by France-based biotech firm Ipsen, has filed for chapter 11 bankruptcy and is about to hire an investment bank to manage a sale process. Ipsen said it had provided $18.3m in debtor-in-possession financing to help manage disposition of Inspiration’s assets and faces a…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
